Browsing: Resectable

Perioperative durvalumab (Imfinzi) plus fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) significantly improved overall survival (OS) vs placebo plus FLOT in…

Chow, F. C. & Chok, K. S. Colorectal liver metastases: an update on multidisciplinary approach. World J. Hepatol. 27 (2),…

Trabectedin (Yondelis) plus radiotherapy was found to be feasible and safe for patients with resectable retroperitoneal L-sarcomas, according to results…

Potent and durable tumor responses were noted with neoadjuvant ipilimumab (Yervoy) plus nivolumab and relatlimab-rmbw (Opdulag) in patients with macroscopic…

Adding IPH5201, an investigational CD39 inhibitor, to perioperative durvalumab (Opdivo) and neoadjuvant chemotherapy produced a promising pathologic complete response (pCR)…

Perioperative nivolumab (Opdivo)-based treatment demonstrated long-term survival among patients with resectable stage IIA to IIIA non–small cell lung cancer (NSCLC),…

IntroductionSoft tissue sarcoma (STS) is an aggressive malignant tumor that accounts for 1% and 25% of all cancers in adults…

Neoadjuvant therapy improves survival outcomes for patients with upfront resectable pancreatic ductal adenocarcinoma and vein abutment, according to data from…